XLXiuqi Li

Xiuqi Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiuqi Li has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modular Peer Review Working Group

    by Working Group Participants, Tony Alves, Femi Qudus Arogundade, Leyla Cabugos, Darian Carroll, Ava Chan, Jonathon Alexis Coates, Hala Taha Elbashir, Lessa Tchohou Fabrice, Mathïs Fédérico, et al.

    Between January and July 2026, the Continuous Science Foundation (CSF) , PREreview , and more than 60 researchers, infrastructure builders, publishers, and community members came together as the Modular Peer Review Working Group . Together, we explored a simple but important question: What might peer review look like if it evolved alongside the research process, rather than centering only on the final paper?

  • Open Access

    Reflection and Experimental Rigor Are Our AiMS: A New Metacognitive Framework for Experimental Design

    by Taralyn Tan, Xiuqi Li

    Experimental design is a core competency of scientific training with profound implications for research rigor and reproducibility. Yet, trainees often receive minimal guidance to structure their thinking around experimental design. Metacognition—reflecting on one's own thinking—offers a powerful tool to strengthen reasoning in this process. Here, we present the AiMS framework, which adapts the classic plan–monitor–evaluate cycle of metacognition to the context of experimental design. This framework emphasizes three iterative stages—Awareness, Analysis, and Adaptation—that scaffold reflection on an experimental system defined by its Models, Methods, and Measurements and evaluated through Specificity, Sensitivity, and Stability. We illustrate application of the AiMS framework through an interactive neuroanatomy case study and provide a structured worksheet to guide readers in applying it to their own experiments. We also highlight how the framework can assist researchers in organizing their ideas for research proposals and explore the responsible use of generative AI as a metacognitive partner that supports structured reflection without supplanting original intellectual contributions. The AiMS framework complements other principles and practices of rigor by foregrounding deliberate reasoning about assumptions, vulnerabilities, and trade-offs. Our goal is to provide practical tools that foster rigor, creativity, and adaptability in the design of biological experiments, supporting both trainees and their mentors in cultivating reflective scientific practices.


  • Open Access

    Evaluating the ASAPbio Crowd Preprint Review Initiative: Experiences, Feedback, and Future Enhancements

    by Xiuqi Li, Josie L. Otto, Lamis Yahia Mohamed Elkheir, Jonathon A Coates

    Traditional peer review faces many challenges, including opacity, bias, and delays in knowledge dissemination. Public, collaborative review of preprints offers an avenue to address these issues by enabling broader feedback prior to journal submission. This study evaluates the experiences and perceptions of participants in the ASAPbio Crowd Preprint Review initiative, an international community-driven preprint review program. Our findings reveal that crowd members represent diverse nationalities, career stages, and scientific disciplines, thereby contributing to the strength of collaborative review by allowing individuals to focus on their area of expertise. Trainees (i.e., students and postdocs) are significant contributors. Participants cite engaging in open science practices, developing peer review skills, and contributing to the scientific community as key motivators. Participants largely expressed satisfaction with the initiative’s design and logistical processes, highlighting its user-friendliness, clear guidelines, effective management, and collaborative environment for skill development. Barriers to participation, primarily limited availability and lack of specific expertise, were also identified. Suggested enhancements include consistent review timing, diversifying topics and reviewers, improving communication, and engaging authors. This evaluation offers valuable insights for refining the ASAPbio initiative and informs other programs seeking to innovate peer review, fostering a more collaborative, transparent, and democratic scientific community.

  • Open Access

    Competency-based Curriculum Mapping for Doctoral Program Evaluation

    by Xiuqi Li, Jelena Patrnogić, David Van Vactor

    Training in the life sciences must continue to evolve to prepare students for challenges in the 21st century. Our program has taken a competency-based approach to meet this need. Here, we report on our efforts to define a competency framework that aligns with our training priorities and apply it to the mapping of our predoctoral curriculum. Systematically collecting and analyzing curriculum data allows us to evaluate a central component of our training program, propelling more holistic and data-driven decisions for improving the program in the future.

  • Open Access

    Research culture in biomedicine: what we learned, and what we would like to do about it

    by Alexa T. McCray, David Van Vactor, James Gould, Xiuqi Li, Jelena Patrnogić, Caroline Shamu, Mary C. Walsh

    The significant stressors that affect the biomedical research community have the potential to negatively impact the conduct of science. Here we report on work done at Harvard Medical School to identify areas for improvement in research rigor, reproducibility, and responsibility in pursuit of continued research excellence. This comment reports on work done at Harvard Medical School to identify areas for improvement in research rigor, reproducibility, and responsibility in pursuit of continued research excellence.


  • Open Access

    Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia

    by Xiuqi Li, Larisa Lozovatsky, Steven M. Tommasini, Jackie Fretz, Karin E. Finberg

    Iron deficiency is a potent stimulator of fibroblast growth factor 23 (FGF23), a hormonal regulator of phosphate and vitamin D metabolism, that is classically thought to be produced by bone-embedded osteocytes. Here, we show that iron-deficient transmembrane serine protease 6 knockout (Tmprss6–/–) mice exhibit elevated circulating FGF23 and Fgf23 messenger RNA (mRNA) upregulation in the bone marrow (BM) but not the cortical bone. To clarify sites of Fgf23 promoter activity in Tmprss6–/– mice, we introduced a heterozygous enhanced green fluorescent protein (eGFP) reporter allele at the endogenous Fgf23 locus. Heterozygous Fgf23 disruption did not alter the severity of systemic iron deficiency or anemia in the Tmprss6–/– mice. Tmprss6–/–Fgf23+/eGFP mice showed green fluorescence in the vascular regions of BM sections and showed a subset of BM endothelial cells that were GFPbright by flow cytometry. Mining of transcriptomic data sets from mice with normal iron balance revealed higher Fgf23 mRNA in BM sinusoidal endothelial cells (BM-SECs) than that in other BM endothelial cell populations. Anti-GFP immunohistochemistry of fixed BM sections from Tmprss6–/–Fgf23+/eGFP mice revealed GFP expression in BM-SECs, which was more intense than in nonanemic controls. In addition, in mice with intact Tmprss6 alleles, Fgf23-eGFP reporter expression increased in BM-SECs following large-volume phlebotomy and also following erythropoietin treatment both ex vivo and in vivo. Collectively, our results identified BM-SECs as a novel site for Fgf23 upregulation in both acute and chronic anemia. Given the elevated serum erythropoietin in both anemic models, our findings raise the possibility that erythropoietin may act directly on BM-SECs to promote FGF23 production during anemia.


  • Open Access

    Bone Marrow Sinusoidal Endothelial Cells Are a Site of Fgf23 Upregulation in Iron Deficiency Anemia

    by Xiuqi Li, Larisa Lozovatsky, Jackie A. Fretz, Karin E. Finberg

    Iron deficiency anemia (IDA) has been identified as a potent stimulator of FGF23 (fibroblast growth factor 23), a phosphaturic hormone classically thought to be produced by bone-embedded osteocytes. Recently, both phlebotomy and erythropoietin administration have been shown to upregulate FGF23 production in bone marrow. However, the cell type(s) mediating FGF23 upregulation in states of perturbed erythropoiesis require further clarification. Tmprss6-/- mice exhibit hepcidin elevation leading to systemic iron deficiency and iron-restricted anemia. We previously reported that Tmprss6-/- mice exhibit altered phosphate balance, elevated circulating FGF23, and Fgf23 mRNA upregulation in bone marrow but not cortical bone. Here, we clarify the sites of Fgf23 promoter activity in Tmprss6 -/- bone marrow using a reporter allele in which the enhanced green fluorescent protein (eGFP) coding sequence has been knocked into the endogenous Fgf23 locus. We generated Tmprss6 +/+,Tmprss6 +/-, and Tmprss6 -/- littermates of both sexes that carried either one (Fgf23 +/eGFP) or zero (Fgf23 +/+) copies of the reporter allele. Tmprss6-/- mice showed hyperhepcidinemia, hypoferremia, microcytic anemia, and tissue iron deficiency, which were not altered by heterozygous Fgf23 disruption (Figure 1A-C). By ELISA, Tmprss6-/- Fgf23 +/eGFP mice showed plasma levels of "total" FGF23 (intact, active hormone and C-terminal cleaved fragments) that remained markedly elevated compared to Tmprss6+/+ littermates (Figure 1D). Total FGF23 elevation in Tmprss6-/- Fgf23 +/eGFP mice was slightly less pronounced than Tmprss6-/- Fgf23 +/+ mice, suggesting an effect of Fgf23 gene dosage. In mice with 2 intact Fgf23 alleles, serum erythropoietin showed a strong linear correlation with plasma total FGF23. By confocal imaging, femurs of mice carrying the Fgf23 eGFP allele showed green fluorescence in vascular regions of the bone marrow but not in the bone cortex. Green fluorescence was more intense in Tmprss6-/- Fgf23+/eGFP mice than non-anemic controls. By flow cytometry of enzymatically digested bone marrow, we observed bright green fluorescence in a subset of endothelial cells (CD45 - Ter119 - CD31 +) exclusively in mice carrying the Fgf23 eGFP reporter allele (Figure 1E). The percentage of endothelial cells that were GFP bright was higher in Tmprss6-/- Fgf23 +/eGFP versus non-anemic mice. To clarify the endothelial cell subtype that expresses Fgf23, we mined published transcriptomic datasets from mice of normal iron balance and discovered higher Fgf23 mRNA in bone marrow sinusoidal endothelial cells compared to other bone marrow endothelial cell populations. Accordingly, we used anti-GFP immunohistochemistry in formalin-fixed bone marrow sections to assess Fgf23 eGFP reporter allele expression in the context of tissue architecture. Tmprss6-/- Fgf23 +/eGFP mice showed GFP expression in bone marrow sinusoidal endothelial cells, which was more intense than in non-anemic controls (Figure 1F). GFP reporter expression was also detected in rare cells of the thymus but not in liver, spleen, heart, muscle, or kidney. Collectively, our data reveal that bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in chronic IDA. Because IDA in Tmprss6-/- mice results from pathologic hepcidin elevation, we also sought to determine if bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in anemic mice with intact hepcidin regulation. We therefore subjected Fgf23 +/eGFP mice (with 2 intact Tmprss6 alleles) to a 500µl phlebotomy regimen (with saline volume replacement) known to induce marked anemia and hepcidin suppression. Compared to non-phlebotomized Fgf23 +/eGFP controls, phlebotomized Fgf23 +/eGFP mice showed severe anemia, elevated serum erythropoietin, and elevated plasma FGF23 18 hours after blood loss. Additionally, immunohistochemistry revealed more intense GFP expression in bone marrow sinusoidal endothelial cells of phlebotomized Fgf23 +/eGFP mice than non-phlebotomized controls. Taken together, our results show for the first time that bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in both acute and chronic anemia. Given the serum erythropoietin elevation in both models, our findings suggest that erythropoietin may act directly or indirectly on sinusoidal endothelial cells to promote FGF23 production during anemia.


  • Open Access

    NCOA4 is Regulated by HIF and Mediates Mobilization of Murine Hepatic Iron Stores After Blood Loss

    by Xiuqi Li, Larisa Lozovatsky, Abitha Sukumaran, Luis Gonzalez, Anisha Jain, Dong Liu, Nadia Ayala-Lopez, Karin E. Finberg

    The mechanisms by which phlebotomy promotes the mobilization of hepatic iron stores are not well understood. NCOA4 (nuclear receptor coactivator 4) is a widely-expressed intracellular protein previously shown to mediate the autophagic degradation of ferritin. Here, we investigate a local requirement for NCOA4 in the regulation of hepatic iron stores and examine mechanisms of NCOA4 regulation. Hepatocyte-targeted Ncoa4 knockdown in non-phlebotomized mice had only modest effects on hepatic ferritin subunit levels and non-heme iron concentration. After phlebotomy, mice with hepatocyte-targeted Ncoa4 knockdown exhibited anemia and hypoferremia similar to control mice with intact Ncoa4 regulation, but showed a markedly impaired ability to lower hepatic ferritin subunit levels and hepatic non-heme iron concentration. This impaired hepatic response was observed even when dietary iron was limited. In both human and murine hepatoma cell lines, treatment with chemicals that stabilize hypoxia inducible factor (HIF), including desferrioxamine, cobalt chloride, and dimethyloxalylglycine, raised NCOA4 mRNA. This NCOA4 mRNA induction occurred within 3 hours, preceded a rise in NCOA4 protein, and was attenuated in the setting of dual HIF-1a and HIF-2a knockdown. In summary, we show for the first time that NCOA4 plays a local role in facilitating iron mobilization from the liver after blood loss and that HIF regulates NCOA4 expression in cells of hepatic origin. Because the prolyl hydroxylases that regulate HIF stability are oxygen and iron-dependent enzymes, our findings suggest a novel mechanism by which hypoxia and iron deficiency may modulate NCOA4 expression to impact iron homeostasis.


  • Open Access

    Trimetazidine improves hepatic lipogenesis and steatosis in non‑alcoholic fatty liver disease via AMPK‑ChREBP pathway

    by Ying Zhang, Can Li, Xiuqi Li, Cheng Wu, Haiyan Zhou, Shuang Lu, Xingde Liu

    Clinical studies have demonstrated that trimetazidine (TMZ) possesses a synergistic hypolipidemic effect together with statins, but the underlying mechanism remains to be elucidated. The present study aimed to investigate the role of TMZ in non‑alcoholic fatty liver disease (NAFLD). By investigating the TMZ treatment of NAFLD, it was identified that high‑fat diet (HFD) mice exhibit significant changes in several physiologic indices, including body weight, plasma lipids and glucose tolerance. Notably, hepatocyte bullous steatosis and fibrosis in HFD mice are greatly attenuated by 8 weeks of TMZ treatments. The results of the present study also indicated that the expression of carbohydrate‑responsive element‑binding protein (ChREBP), fatty acid synthase and acetyl‑CoA carboxylase were all significantly reduced in the HFD + TMZ group compared with the HFD group. In order to confirm the hypothesis in vitro, the palmitate‑treated liver cancer cell line (HepG2) was employed and similar results were obtained in TMZ‑treated HepG2 cells. Furthermore, TMZ markedly upregulated the AMP‑activated protein kinase (AMPK) signaling pathway and reduced the expression of forkhead box O1 (FOXO1) in the cells, while these effects controlled by TMZ were abolished by the AMPK inhibitor Compound C. The present study reported that knockdown of FOXO1 expression by FOXO1 small interfering RNA resulted in a reduction of ChREBP protein expression and post‑transcriptional activity. In summary, for the first time, to the best of the authors' knowledge, the present study revealed a novel role of TMZ in hepatic steatosis; TMZ ameliorated ChREBP‑induced de novo lipogenesis by activating the AMPK‑FOXO1 pathway.


  • Open Access

    IL-1β Drives Production of FGF-23 at the Onset of Chronic Kidney Disease in Mice

    by Quiana McKnight, Sarah Jenkins, Xiuqi Li, Tracy Nelson, Arnaud Marlier, Lloyd G. Cantley, Karin E Finberg, Jackie A Fretz

    FGF‐23 has arisen as an early biomarker of renal dysfunction, but at the onset of chronic kidney disease (CKD) data suggest that FGF‐23 may be produced independently of the parathyroid hormone (PTH), 1,25(OH)2‐Vitamin D3 signaling axis. Iron status is inversely correlated to the level of circulating FGF‐23, and improvement in iron bioavailability within patients correlates with a decrease in FGF‐23. Alternately, recent evidence also supports a regulatory role of inflammatory cytokines in the modulation of FGF‐23 expression. To determine the identity of the signal from the kidney inducing upregulation of osteocytic FGF‐23 at the onset of CKD we utilized a mouse model of congenital CKD that fails to properly mature the glomerular capillary tuft. We profiled the sequential presentation of indicators of renal dysfunction, phosphate imbalance, and iron bioavailability and transport to identify the events that initiate osteocytic production of FGF‐23 during the onset of CKD. We report here that elevations in circulating intact‐FGF‐23 coincide with the earliest indicators of renal dysfunction (P14), and precede changes in serum phosphate or iron homeostasis. Serum PTH was also not changed within the first month. Instead, production of the inflammatory protein IL‐1β from the kidney and systemic elevation of it in the circulation matched the induction of FGF‐23. IL‐1β's ability to induce FGF‐23 was confirmed on bone chips in culture, and within mice in vivo. Furthermore, neutralizing antibody to IL‐1β blocked FGF‐23 expression in both our congenital model of CKD and a second nephrotoxic serum‐mediated model. We conclude that early CKD resembles a situation of primary FGF‐23 excess mediated by inflammation. These findings do not preclude that altered mineral availability or anemia can later modulate FGF‐23 levels, but find that in early CKD they are not the driving stimulus for the initial upregulation of FGF‐23.